American Journal of Medical Case Reports
ISSN (Print): 2374-2151 ISSN (Online): 2374-216X Website: http://www.sciepub.com/journal/ajmcr Editor-in-chief: Apply for this position
Open Access
Journal Browser
Go
American Journal of Medical Case Reports. 2014, 2(2), 39-40
DOI: 10.12691/ajmcr-2-2-3
Open AccessCase Report

Effect of Intravitreal Moxifloxacin in Acute Post Traumatic Endophthalmitis

Muhammad Khizar Niazi1, Muhammad Dawood Khan2, Muhammad Aamir Arain3, Lubna Adeeb4 and Shazia Yasir5,

1Assoc Prof of Ophthalmology Armed Forces Institute of Ophthalmology Rawalpindi, Pakistan

2Senior Consultant, Noor Eye Centre, Basharat Hospital Rawalpindi, Pakistan

3Consultant Ophthalmologist, PAC Hospital, Kamra, Attock, Pakistan

4Resident Ophthalmology, POF Hospital Wah Cantt, Pakistan ER Physician (PG)

5Ziauddin University, Karachi, Pakistan

Pub. Date: March 02, 2014

Cite this paper:
Muhammad Khizar Niazi, Muhammad Dawood Khan, Muhammad Aamir Arain, Lubna Adeeb and Shazia Yasir. Effect of Intravitreal Moxifloxacin in Acute Post Traumatic Endophthalmitis. American Journal of Medical Case Reports. 2014; 2(2):39-40. doi: 10.12691/ajmcr-2-2-3

Abstract

We describe results of intravitreal moxifloxacin in a case of acute post traumatic endophthalmitis & cataract developed after sustaining a penetrating ocular injury. Management included topical and intravitreal moxifloxacin. The intravitreal injection was given at the time of presentation and then was repeated after 48 hours when lens aspiration and anterior vitrectomy was performed. The patient showed a rapid recovery, and achieved 6/6 vision following surgery. To our knowledge this is the first reported case of therapeutic use of intravitreal moxifloxacin in a human case of acute post traumatic endophthalmitis. Presentation of Case: We report a case of a twenty one year old male referred to us with two days history of penetrating injury in left eye due to a piece of metallic wire. After five days of hospitalization, he was discharged with 6/6 partial best corrected vision. Consent: The patient and his family have given informed consent for the publication of this case report.

Keywords:
endophthalmitis; intravitreal moxifloxacin; anterior vitrectomy

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Thompson WS, Rubsamen PE, Flynn HW Jr, Schiffman J, Cousins SW. Endophthalmitis after penetrating trauma: risk factors and visual acuity outcomes. Ophthalmology 1995; 102: 1696-701.
 
[2]  Han DP, Wisniewski SR, Wilson LA. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol 1996; 122: 1-17.
 
[3]  Soheilian M, Rafati N, Mohebbi MR, Yazdani S, Habibabadi HF, et al. The Traumatic Endophthalmitis Trial (TET) Research Group Prophylaxis of Acute Posttraumatic Bacterial Endophthalmitis. A multicenter randomized clinical trial of intraocular antibiotic injection, Report 2 Arch Ophthalmol 2007; 125 (4): 460-5.
 
[4]  Yagci R, Oflu Y, Dincel A, Kaya E, Yagci S, Bayar B, Duman S, Bozkurt A. Penetration of second, third and fourth generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model. Eye 2007; 21 (7): 990-4.
 
[5]  Chaudhry IA, Shamsi FA, Harthi EA, Theeb AA, Elzaridi E, Riley FC. Incidence and visual outcome of endophthalmitis associated with intraocular foreign bodies. Graefes Arch Clin Exp Ophthalmol 2008; 246 (2): 181-6.
 
[6]  Meredith TA. Posttraumatic Endophthalmitis. Editorial Arch Ophthalmol 1999; 117 (4): 520-1.
 
[7]  Mah FS. Fourth-generation fluoroquinolones: new topical agents in the war on ocular bacterial infections. Curr Opin Ophthalmol 2004; 15: 316-20.
 
[8]  Kunimoto DY, Das T, Sharma S, Jalali S, Majji AB, Gopinathan U, et al. Microbiologic spectrum and susceptibility of isolates: part II. Posttraumatic endophthalmitis. Endophthalmitis Research Group. Am J Ophthalmol 1999; 128: 242-4.
 
[9]  Kernt M, Neubauer AS, Ulbig MW, Kampik A, Welge-Lussen U. In vitro safety of intravitreal moxifloxacin for endophthalmitis treatment. J Cataract Refract Surg 2008; 34(3): 480-8.
 
[10]  Kowalski RP, Romanowski EG, Mah FS, Yates KA, Gordon YJ. Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model. Am J Ophthalmol 2005; 140 (3): 497-504.
 
[11]  ESCRS Endophthalmitis Study Group: Prophylaxis of post-operative endophthalmitis following cataract surgery: results of the ESCRS multi-centre study and indentification of rist factors. J Cataract Refract Surg 2007; 33: 978-88.
 
[12]  Peyman G, Lee P, Seal DV. Endophthalmitis-Diagnosis and management. London, Taylor and Francis Group, 2004, 1-270.